PhD Studentship: Identification Of Novel Biomarkers And Drug Targets In Genetically Stratified Meningiomas
Health and Medical,Medicine and Dentistry
Short info about job
Company: University of Plymouth
Department: Plymouth University Peninsula Schools of Medicine & Dentistry
Hours: Full Time, Part Time
Type / Role: PhD
Phone: +44-1339 8490753
Fax: +44-1458 5268188
E-mail: N\A
Site: N\A
Detail information about job PhD Studentship: Identification Of Novel Biomarkers And Drug Targets In Genetically Stratified Meningiomas. Terms and conditions vacancy
Start date: 1 January 2018
Director of Studies: Prof. C. Oliver Hanemann
2nd Supervisor: Dr. Sara Ferluga
3rd Supervisor: Dr. Claire Adams
Plymouth University Peninsula Schools of Medicine & Dentistry are seeking to attract PhD candidates of outstanding ability to join their exciting and rapidly expanding programme of internationally-rated research. The Plymouth University Peninsula Schools of Medicine & Dentistry are committed to research excellence with a recent £25 million investment in staff and facilities. Medical research at PUPSMD was ranked first for outputs in REF2014.
Applications are invited from highly motivated qualified graduates, 2:1 or above, and preferably a relevant MSc or MRes qualification. International students must also have an IELTS score of 7.0 or above (with no less than 6.5 in any element).
Meningiomas are the most common brain tumours affecting brain and spinal cord. The heterogeneity of these tumours and the profound lack of knowledge about specific markers contribute to make the development of new therapeutics challenging. However, the genetic background of meningioma is well characterized with the loss/mutation of the gene NF2 (Merlin) being the most common together with other sporadic mutations identified in NF2+/+ meningiomas. Sporadic mutations includes TRAF7, KLF4, SMO and AKT1.
To characterize the molecular signature of meningiomas we use an unbiased proteomic approach that involves the analysis of the proteome and the phosphoproteome of primary meningioma cells and tissue. The student will carry out proteome analysis of stratified meningiomas with TRAF7/KLF4 and AKT1/TRAF7 mutations, comparing the total and phosphoproteome of these to our existing datasets. To verify potential drug targets within these meningioma subgroups, we will use our well-established in vitro model and functional assays.
For further information regarding the project, please contact Dr. Sara Ferluga ([email protected]). However, applications must be made in accordance with the details shown below.
Funding Notes: The stipend will be approx. £14,553 per annum. Tuition fees will be paid at the home/EU rate. Candidates who are not eligible for Home/EU fees will be liable for the difference between 'home student fees' and 'international student fees’. For the 17/18 academic year the difference in fee is £10,350. If you are selected you will be required to provide financial assurances.
To Apply:
Follow the link https://www.plymouth.ac.uk/student-life/your-studies/doctoral-college/applicants-and-enquirers and click ‘Apply online’ to access the application form. Please mark the application ref: PUPSMD-16-17-017. Please Note: you do not need to submit a project proposal with your application.
Further information on the application process. If you have any questions on the admissions process contact [email protected]
The closing date for applications is 12 noon on 31st October 2017. Shortlisted candidates will be invited for interview. We regret that we may not be able to respond to all applications. Applicants who have not received an offer of a place by 5th December 2017 should consider their application has been unsuccessful on this occasion.